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School of Medicine, University of St Andrews, Medical and Biological Sciences Building, North Haugh, St Andrews, Fife, UKAbstractIn 2004 a large focus of Plasmodium knowlesi malaria was reported in the human population in Sarawak, Malaysian Borneo. Plasmodium knowlesi,
a parasite of the South-East Asian macaques (Macaca fascicularis and Macaca nemestrina), had entered the human population. Plasmodium
knowlesi is transmitted by the leucosphyrus group of Anopheline mosquitoes and transmission is largely zoonotic and restricted to the
jungle setting. Humans entering jungle transmission sites are at risk. Since 2004, human cases of P. knowlesi have been continuously
reported in local communities and in travellers returning from South East Asia. Plasmodium knowlesi is the most common type of
indigenous malaria reported in Malaysia. Infections are most often uncomplicated but at least 10% of patients report with severe malaria
and 1–2% of cases have a fatal outcome. Parasitaemia is positively associated with the clinical and laboratory markers of severe malaria.
The current literature on P. knowlesi, including epidemiology, natural hosts and vectors, pathogenesis, clinical descriptions, treatment and
diagnosis, is reviewed. There are many gaps in our understanding of this disease that are highlighted here with suggestions for further
research to inform pre-emptive control measures that would be required to prevent a full emergence of this parasite into the human
population.
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E-mail: jcs26@st-andrews.ac.ukIntroductionMalaria is caused by parasites that are member species within
the genus Plasmodium. Plasmodium falciparum, Plasmodium vivax,
Plasmodium ovale (exists as two subspecies) and Plasmodium
malariae account for almost all cases of malaria in the human
population [1]. They are human-host adapted and are trans-
mitted from person to person by female Anopheline mosqui-
toes and, as is typical of the genus, grow and replicate inside the
vertebrate host red blood cells. Plasmodium species are not
restricted to human infections and more than 100 species have
evolved and co-exist with other vertebrates including birds,
rodents and non-human primates [2]. Plasmodium speciesMicrobiol Infect 2015; 21: 640–648
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other hosts even when two hosts have very similar parasites
[3]. An exception to this is Plasmodium knowlesi, a parasite
adapted to the South-East Asian macaques. Plasmodium knowlesi
was discovered in 1932 in Macaca fascicularis (long-tailed ma-
caque) and since then has been maintained experimentally in
Macaca mulata (Rhesus macaques) and was successfully trans-
ferred to other non-human primates and human volunteers
under experimental conditions [4,5]. Naturally acquired
P. knowlesi infections in the human population were thought to
be rare with only one conﬁrmed case, in 1965 [6].
Plasmodium knowlesi is morphologically similar to the human-
host-adapted P. malariae that is transmitted between human
hosts and causes mild and often self-resolving malaria with low
parasite counts (the number of parasite-infected red blood
cells/μL of blood) [4]. A large entry of P. knowlesi was discov-
ered in the human population in the Kapit district of Sarawak,
Malaysian Borneo during an investigation of atypical cases of
P. malariae, where patients were reporting with symptoms and
uncharacteristically high parasite counts (parasitaemia) [7].ious Diseases. Published by Elsevier Ltd. All rights reserved
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infections was sequenced [7]. The sequences aligned with
P. knowlesi reference sequences and were quite distinct from
P. malariae. Patients with all-cause malaria were then recruited
and their malaria parasites were identiﬁed using Plasmodium
species-speciﬁc PCR. Of the 208 patients in the study,
P. knowlesi was the most common cause of malaria [7]. Since
then there have been studies on the prevalence and distribu-
tion of P. knowlesi in South-East Asia and even though
P. malariae is still reported by microscopy, molecular methods
suggest that P. malariae is rare in South-East Asia and P. knowesi
malaria is widespread [8–10]. Since the report of the discov-
ery of P. knowlesi malaria in the human population in 2004 the
disease has been clinically characterized and P. knowlesi is now
recognized as the ﬁfth cause of malaria in humans [11]. Here
we review the current literature on P. knowlesi including
epidemiology, natural hosts and vectors, pathogenesis and
diagnosis.EpidemiologyFollowing the discovery of P. knowlesi in the Kapit district of
Sarawak, blood samples from patients with malaria at other
sites in Malaysia were screened using Plasmodium species-
speciﬁc PCR. Surprisingly the entry was not restricted to the
Kapit district but cases of P. knowlesi malaria were widespread
in Sarawak, Sabah, also Malaysian Borneo, and mainland
Malaysia and P. malariae was rare [8]. The Plasmodium species
normally associated with malaria in humans, P. falciparum and
P. vivax, are largely under control in island and mainland
Malaysia and currently P. knowlesi is the main cause of indige-
nous malaria in Malaysia [10].
The number of cases of P. knowlesi malaria in Sarawak is not
in decline and the number of notiﬁed cases of P. knowlesi in
Sabah increased from 703 in 2011 to 996 in 2013 [9]. Addi-
tionally, P. knowlesi appears to have increased in the Hulu
Selangor district of Peninsular Malaysia from 21 cases in 2009 to
41 cases in 2013, peaking at 43 cases in 2011 [12].
In addition to Malaysia, P. knowlesi has been identiﬁed across
South-East Asia with cases conﬁrmed in Cambodia, Indonesia,
Myanmar, Philippines, Singapore, Thailand and Vietnam
[13–20]. Additionally, P. knowlesi cases were reported in
Australia, Finland, France, Germany, Japan, the Netherlands,
New Zealand, Scotland, Spain, Sweden and Taiwan in travellers
returning home from P. knowlesi transmission zones in South-
East Asia [14,21–33]. Taken together with the ﬁgures from
Malaysia and the wide distribution of cases reported across
South-East Asia, the multiple entries of P. knowlesi into the
human population appears to be sustained.Clinical Microbiology and Infection © 2015 European Society of Clinical MicrobiologyStudies so far tend to conﬁrm that P. knowlesi transmission is
largely restricted to the jungles of South-East Asia because this
is the preferred habitat of the particular Anopheline vectors of
P. knowlesi [34–36]. People who are engaged in agriculture,
forestry, hunting or leisure activities in the jungle setting are at
risk.The natural hosts of P. knowlesiParasitologists in the twentieth century found that the pre-
dominant simian hosts of P. knowlesi are M. fascicularis (long-
tailed macaques) and Macaca nemestrina (pig-tailed macaques),
which are indigenous to South-East Asia [4,37]. However,
although these macaques are suspected of being the natural
reservoirs for the human P. knowlesi infections reported over
the past 10 years, parasitology data from local macaque pop-
ulations are sparse. Nonetheless P. knowlesi has been detected
in wild populations of M. fascicularis in Malaysia, Singapore and
Thailand, and M. nemestrina in Malaysia and Thailand
[17,18,38–40]. For example, in Peninsular Malaysia
143 M. fascicularis individuals were trapped and screened for
P. knowlesi by PCR [39]. Ten animals were positive for
P. knowlesi [39]. In Singapore, three M. fascicularis monkeys,
trapped in an area where humans were thought to have been
infected, had multiple P. knowlesi genotype infections whereas
ten macaques from a nature reserve were all negative for
P. knowlesi [17]. A recent molecular study on the macaques in
the Kapit division of Sarawak, Malaysian Borneo, where the ﬁrst
large focus of P. knowlesi was identiﬁed in the human population
[7], found that M. fascicularis and M. nemestrina macaques were
infected with multiple Plasmodium species including P. knowlesi,
Plasmodium inui, Plasmodium cynomolgi, Plasmodium ﬁeldi and
Plasmodium coatneyi [38]. Additionally, some of the macaques
were infected with multiple genotypes of P. knowlesi [38]. Plas-
modium knowlesi DNA sequences from macaques and human
cases of P. knowlesi in the same area were compared. There was
no evidence of clustering of P. knowlesi genotypes in either host
species that would indicate a host switch event of the parasite
from macaques to humans [38]. The fact that parasite geno-
types seemed to be shared between macaques and humans
supports the idea that, in the Kapit division of Sarawak,
P. knowlesi remains zoonotic [38]. The South-East Asian ma-
caque populations are relatively large and the main reservoir of
P. knowlesi, but other non-human primates may well be infected.
In Thailand, blood collected from a leaf monkey, Semnopithecus
obscurus, was positive for Plasmodium species with similarity to
P. knowlesi [41]. In earlier studies the banded leaf monkey was
identiﬁed as one of the natural hosts of P. knowlesi [18,41,42].
The macaque populations in South-East Asia are currentlyand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 640–648
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the human population are observed across South-East Asia.
This information, taken together with the potential for severe
disease and the uncertainty of a host-switch event having taken
place, it would seem pertinent to generate more data on the
reservoirs of P. knowlesi that would be representative of the
region. Recently a model was developed to predict the likeli-
hood of P. knowlesi malaria occurring in speciﬁc areas within
South-East Asia [40]. However, local information on reservoirs
of infection, vectors and human cases of P. knowlesi is required
to enter into the model [40]. Generating this kind of data,
particularly on the vectors and reservoirs of P. knowlesi is not
trivial, but if the goal is to predict and monitor unusual out-
breaks of P. knowlesi in South-East Asia then representative data
are essential.Anopheline vectors of P. knowlesiTransmission of P. knowlesi is restricted to the Anopheles leu-
cosphyrus group of mosquito vectors that are found in South-
East Asia [4,43,44]. The group is diverse with many species
found across the region, each with differing vectorial capacities
[43]. The group includes vectors not only of P. knowlesi but
also of P. falciparum and P. vivax. Although the number of
studies is small, mosquitoes at suspected jungle transmission
sites of P. knowlesi, including those in Malaysian Borneo
[35,45–47], Hulu Selangor (Peninsular Malaysia) [12], Kuala
Lipis (Peninsular Malaysia) [36,39] and Khanh Phu (South
Vietnam) [20] were sampled for P. knowlesi carriage. Anopheles
balabacensis is implicated in P. knowlesi transmission in Sabah
Malaysian Borneo [46,47]. In Sarawak the main vector of
P. knowlesi in the Kapit Division was Anopheles latens [35].
Anopheles latens feeds on humans and long-tailed macaques and
was therefore incriminated as the vector of P. knowlesi in this
region of Sarawak [35]. In Hulu Selangor, peninsular Malaysia,
Anopheles maculatus was the predominant malaria vector
species and one of 265 mosquito samples had P. knowlesi oo-
cysts [12]. Two studies from Kuala Lipis, 100 km from Hulu
Selangor, reported that Anopheles cracens, also within the leu-
cosphyrus group, was the predominant malaria vector [36]. Five
A. cracens were positive for P. knowlesi sporozoites or oocysts,
two of these were obtained by human bait collection [36,39].
One of these studies included a village setting where A. cracens,
A. maculatus and Anopheles aconitus were all captured outdoors
but none of these species were found inside human dwellings,
therefore reducing the likelihood of human-to-human trans-
mission of P. knowlesi within households [36]. In Khanh Phu,
southern Vietnam, Anopheles dirus was identiﬁed as the pre-
dominant malaria vector species [20]. Interestingly someClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectA. dirus mosquitoes were multiply infected with P. knowlesi,
P. falciparum, P. vivax and P. malariae [20].
The complexity and diversity of the leucosphyrus group of
mosquitoes in South-East Asia precludes extrapolation of in-
formation between locations. Therefore collecting represen-
tative information on the local vectors of P. knowlesi within the
region is important to identify areas where the human popu-
lation is at risk [40], and also to monitor changes in vector
behaviour that may predict a host switch for P. knowlesi from
macaques to human-to-human transmission.Plasmodium knowlesi pathogenesis and
parasite diversityIn malaria it is unclear why certain individuals develop severe
disease while others present with uncomplicated infections.
Studies can be equivocal but it is certain that both host and
parasite variability contribute to severe malaria [48]. For
example, P. falciparum and P. knowlesi reach very high parasite
counts in some patients and hyperparasitaemia is associated
with severe disease in both of these types of malaria [49].
However, it is not known if some hosts are particularly sus-
ceptible to Plasmodium infection or if some parasites grow more
efﬁciently or are more virulent in the human host.
Hyperparasitaemia and invasion efﬁciency
Patients with P. knowlesi malaria present with a range of para-
sitaemias from 1 to 764 720/μL, even though the duration of
symptoms before presentation can be relatively short [8]. A
recent study examined the possibility that variation in
P. knowlesi proteins involved in parasite invasion of host
erythrocytes may confer an invasion advantage to particular
parasite genotypes and lead to high parasite counts [50]. Poly-
morphic regions of the two P. knowlesi members of an impor-
tant invasion gene family in Plasmodium species (P. knowlesi
normocyte binding protein (Pknbp) xa and Pknbpxb) [51] were
sequenced in patient isolates [50]. Particular alleles of both
genes clustered with clinical and laboratory markers of severe
disease [50]. Although this work is preliminary, the results
suggest that certain genetic variants of P. knowlesi are more
virulent in the human host.
Parasite sequestration in P. knowlesi
Severe malaria with coma in P. falciparum malaria is accom-
panied by sequestration of parasite-infected erythrocytes in
the brain [52]. Although incompletely understood, seques-
tration in P. falciparum is mediated by the expression of the var
gene family of proteins, PfEMP1, on the surface of infected
erythrocytes [53–56]. Plasmodium knowlesi parasites expressious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 640–648
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the surface of infected erythrocytes that are also encoded by a
variant multigene family [55–60]. PfEMP1 proteins predomi-
nantly bind to CD36, a receptor that is constitutively
expressed on human endothelial cells, except on brain
endothelium where they bind to up-regulated intercellular
adhesion molecule 1 and to each other to form rosettes
[61–65]. Severe malaria with coma has not been reported in
severe cases of P. knowlesi malaria even though sequestration
of parasitized erythrocytes, similar to that found in severe
falciparum malaria with coma, was observed in post mortem
brain sections taken from a fatal case of P. knowlesi malaria
[66]. A subsequent study found that P. knowlesi-infected
erythrocytes, matured ex vivo, bound to intercellular adhesion
molecule 1 and/or vascular cell adhesion molecule 1 but not
CD36 [67]. The study was small but highlighted the potential
not only for sequestration but also cytoadherence in
P. knowlesi malaria. Further work on schizont-infected cell
agglutination variants and their contribution to P. knowlesi
virulence may well provide insight into the role of parasite
sequestration, cytoadherence and disease severity, including
severe disease with coma, in malaria.Clinical presentationPlasmodium knowlesi infections are characterized by daily,
symptomatic episodes because of the unique 24-h asexual
(erythrocytic) life cycle of P. knowlesi. The asexual life cycle
takes at least 48 h in all of the other Plasmodium species that
infect humans and non-human primates. The ﬁrst detailed
clinical descriptions of P. knowlesi malaria were provided by
Daneshvar et al. [34]. The study included baseline pre-
treatment signs, symptoms and clinical laboratory data for a
patient cohort (n = 107) in Kapit, Sarawak [34]. The predom-
inant symptoms were; fever and chills (100% of patients),
headache (94.4%), rigors (89.7%), malaise (89.7%), myalgia
(87.9%), cough (56.1%), nausea (56.1%), abdominal pain
(52.3%), vomiting (33.6%) and diarrhoea (29%) [34]. Patients
had a median axillary temperature of 37.6°C, median respira-
tory rate of 26 breaths/min, mean pulse rate of 95 beats per
minute and mean arterial blood pressure of 89 mmHg [34]. Ten
of the 107 (9.3%) patients had severe malaria but none had
severe malaria with coma [34].
Subsequently four studies compared patients presenting
with uncomplicated and severe knowlesi malaria to determine
the clinical and laboratory markers of severe disease. The
studies comprised 130 [68], 110 [69], 94 [70] and 56 [71]
patients, of whom 38 (29%), 17 (15%), 9 (9.5%) and 22
(39%), respectively, had severe disease [68–71]. TheClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologydifference in the proportion of patients with severe disease
(9–39%) at the different study sites reﬂects recruitment at
peripheral hospitals [34,69] and at a referral hospital where
the proportion of severe cases would be expected to be
higher [68,71]. In addition parasite diversity and associated
virulence at different study locations may affect the proportion
of patients with severe disease (see Hyperparasitaemia and
Invasion efﬁciency section) [50]. Parasitaemia is associated
with disease severity in P. knowlesi infections [34] and in three
studies the geometric mean parasitaemia in uncomplicated
P. knowlesi malaria was between 1030 and 4837 parasites/μL of
blood [68–70]. However for severe disease the geometric
mean parasitaemia was 94 256 (18 500–290 000 interquartile
range) [69], 80 359 (26 000–170 000 interquartile range) [68]
and 21 715 (4300–150 000 interquartile range) [70] parasites/
μL, respectively. Thrombocytopenia is a characteristic feature
of P. knowlesi infection [34,72]. All studies that compared un-
complicated with complicated P. knowlesi malaria reported
even lower platelet counts in patients with severe disease
[68–71]. The clinical descriptions of P. knowlesi were recently
reviewed in detail (see Singh & Daneshvar [73]), and in
returning travellers (see Muller & Schlagenhauf [74]).
Patients with severe knowlesi malaria fulﬁl the WHO criteria
for severe malaria apart from severe anaemia and coma [49].
Four fatal cases of P. knowlesi malaria were reported in 2008 [8].
Since then prospective and retrospective studies have recorded
mortality rates of 1.8–10.7%; however, the higher ﬁgures are
biased by recruitment in a referral hospital [68–71]. Prospec-
tive studies at district hospital level suggest that 1–2% of pa-
tients with knowlesi malaria have a fatal outcome [34].
Importantly a recent study in Sabah reported no deaths in all
patients with P. knowlesi who were ill enough to require referral
to a specialist centre, when they received pre-referral intra-
venous artesunate [68]. Intravenous artesunate had a faster
parasite clearance time when compared with treatment with
intravenous quinine [71] and parasites responded uniformly
well ex vivo to artesunate when compared with chloroquine,
meﬂoquine and artemisinin [75]. Interestingly in one of our
recent studies a 57-year-old female patient presented with
794 000 parasites/μL blood with numerous multiply infected
erythrocytes. On admission her white cell count was 16 500/μL
(83% neutrophils), haemoglobin 9.1 g/dL, packed cell volume
25%, platelets 39 000/μL, serum creatinine 359 μmol/L, serum
urea 32 mmol/L, total serum bilirubin 56.1 μmol/L with
32.4 μmol/L as conjugated bilirubin. The patient was treated
with intravenous artesunate in combination with doxycycline
and survived, and although not enrolled in a study on treatment
response, this case supports the important recommendation by
Barber et al., for the use of IV artesunate to treat severe
P. knowlesi malaria [68].and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 640–648
644 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIP. knowlesi diagnosisTraditionally malaria is diagnosed by examining stained thick
and thin blood ﬁlms by microscopy. Malaria parasites are visible
as stained bodies inside red blood cells (Fig. 1). The human host
adapted parasites P. falciparum, P. vivax, P. malariae and P. ovale
have unique morphological characteristics that are used to
identify the species of Plasmodium responsible. However, the
entry of P. knowlesi into the human population has complicated
diagnosis based on parasite morphology. Plasmodium knowlesi
and P. malariae share morphological characteristics and there-
fore cannot be differentiated by microscopy. Plasmodium
malariae replicates every 72 h, preferentially invades older
erythrocytes, has a low parasitaemia and patients do not
develop severe symptoms [76], therefore misdiagnosis is not a
problem. However, P. knowlesi replicates every 24 h, can rapidly
reach high parasitaemias and can cause severe and fatal malaria
[8]. Therefore patients with P. knowlesi malaria require accurateFIG. 1. Red blood cells infected with asexual stage parasites in Giemsa-stained
trophozoite (ring stage); (b) trophozoite with increased blue-stained cytoplasm
of the cytoplasm); (c) schizont containing ten merozoites, daughter parasites,
undergoing egress to release merozoites to infect new red blood cells. The co
cell to schizont rupture in P. knowlesi takes 24 h.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectand prompt diagnosis and treatment. Misdiagnosing P. knowlesi
as P. malariae can have severe consequences [8,77]. In addition
to the absence of morphological characteristics to distinguish
P. knowlesi from P. malariae, microscopy is error prone and
other species can also be misdiagnosed [7,8,78,79]. The prob-
lems encountered with misdiagnosis when using only micro-
scopy highlight the need for the development of sensitive and
speciﬁc methods to accurately diagnose malaria in a timely
fashion.
Antigen-based rapid diagnostic tests for malaria
Antigen-based rapid diagnostic tests (aRDTs) for malaria were
introduced to provide bedside diagnosis without the need for
microscopy. Several commercially available aRDTs include a
Pan-Plasmodium reagent to detect P. falciparum, P. vivax,
P. malariae and P. ovale in addition to a P. falciparum-speciﬁc
reagent (Table 1). The aRDTs were recently evaluated for
cross-reactivity with P. knowlesi [80–83]. The OptiMAL-IT
assay had the highest sensitivity for fresh and frozen wholethin blood ﬁlms from patients with Plasmodium knowlesimalaria: (a) early
and diffuse hemozoin pigment grains (yellowish areas at the periphery
with clumped pigment present (densely stained body); and (d) schizont
mplete erythrocytic cycle from merozoite invasion of a target red blood
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 640–648
TABLE 1. Summary of the antibody reagents used in commercially available antigen detection rapid diagnostic tests (aRDTs) for
malaria diagnosis
Commercially available aRDTs Pan Plasmodium reagent Plasmodium falciparum reagent Plasmodium vivax reagent Reference
OptiMAL-IT
(DiaMed)
pLDH PfLDH — [80,81,83]
BinaxNOW® Malaria
(Inverness Medical)
pAldolase PfHRP2 — [81]
Paramax-3
(Zephyr Biomedical systems)
pLDH PfHRP2 PvLDH [81]
CareStart™ Malaria
(Access Bio, Inc.)
pLDH PfHRP2 — [80]
ParaHIT®
(Span Diagnostics Ltd.)
pAldolase PfHRP2 — [82]
First Response®
(Premier Medical Corporation Ltd.)
pLDH PfHRP2 — [82]
Entebe
(Laboratorium Hepatika)
— PfHRP2 PvLDH [83]
CMI Millar and Cox-Singh Plasmodium knowlesi malaria 645blood from PCR-conﬁrmed single-species P. knowlesi infections,
71% (20/28) and 73% (30/41), respectively [81]. However, 90%
(18/20) of the Pan-positive P. knowlesi samples were also posi-
tive for P. falciparum PfLDH. Only 10% of the P. knowlesi sam-
ples were identiﬁed as non-P. falciparum malaria using
OptiMAL-IT [81]. Therefore the OptiMAL-IT test was not
recommended for diagnosing malaria in areas where P. knowlesi
malaria occurs [81]. The BinaxNOW® and Paramax-3 tests
both had low sensitivities for P. knowlesi and BinaxNOW® was
negative for all samples <5000 parasites/μL [81]. Additionally,
P. knowlesi samples cross-reacted with the P. vivax LDH
(PvLDH) reagent in the Paramax-3 test kit [81]. Cross-
reactivity between P. knowlesi and the OptMAL-IT PfLDH re-
agent and P. knowlesi with the Entebe MC PvLDH reagent was
previously reported when aRDTs were evaluated using
P. knowlesi-infected Japanese macaques [83]. Plasmodium knowl-
esi did not react with PfHRP2 antibodies but reacted with
PvLDH as in the Paramax-3 assay [81,83]. Further studies have
suggested that P. knowlesi identiﬁcation can be achieved using a
combination of OptiMAL-IT and CareStart™ aRDTs; however,
correct P. knowlesi identiﬁcation was still less sensitive than
microscopy [80]. Additionally, interpreting the complex rami-
ﬁcations of using multiple RDTs to diagnose P. knowlesi at the
bedside is not practically feasible or economically viable. First
Response® and ParaHIT® aRDTs were tested for their ability
to identify P. knowlesi, P. falciparum and P. vivax infections [82].
However the sensitivity was poor for both aRDTs in identifying
P. knowlesi infections, particularly in patients with uncompli-
cated disease [82]. Patients with P. knowlesi malaria are symp-
tomatic at very low parasitaemia, therefore not only is
speciﬁcity important but sensitivity is paramount [32,34]. Plas-
modium knowlesi replicates daily and can rapidly progress to life-
threatening hyperparasitaemia [8]. Any diagnostic test devel-
oped for P. knowlesi must be speciﬁc and sensitive enough to
ensure early diagnosis, especially in the rural setting [34].Clinical Microbiology and Infection © 2015 European Society of Clinical MicrobiologyPCR for P. knowlesi detection
Currently, PCR is the only method that can accurately identify
P. knowlesi parasites. Nested-PCR was required to improve
sensitivity, particularly when detecting P. knowlesi in isolates
from patients with low parasitaemia [7]. Often nested-PCR is
used to retrospectively conﬁrm the Plasmodium species when
P. knowlesi is suspected [8,10,13,16,26,32,34–36]. However,
although nested-PCR is speciﬁc it is not practical for malaria
diagnosis [79,84]. A sensitive multiplex quantitative PCR assay
for malaria, that includes P. knowlesi detection, has been
developed with 100% sensitivity and speciﬁcity for P. knowlesi
[85]. This assay requires a ﬁve-colour real-time PCR cycler and,
although rapid, is practically prohibitive for malaria diagnosis in
endemic countries. In addition, processing one sample at a time
for rapid diagnosis of individual patients presenting with fever
would also be impractical. However, for epidemiology and PCR
conﬁrmation this assay has the advantage of speed and is a
single-tube assay. The commercially available PlasmoNex
multiplex PCR system for malaria includes species-speciﬁc
primers for P. knowlesi but requires gel electrophoresis
[86,87]. Although speciﬁc and sensitive this method is not
practical for malaria diagnosis.
Loop-mediated isothermal ampliﬁcation
A PCR-based technology to harness speciﬁcity and sensitivity
but in a rapid and affordable format has been developed. Loop-
mediated isothermal ampliﬁcation (LAMP) involves a complex
mix of speciﬁcally engineered nucleic acid primers that combine
speciﬁc binding to target DNA and self-binding to support loop
priming in subsequent ampliﬁcation rounds [88]. As a result
large DNA structures and insoluble salts are formed in positive
reactions that allow for easy detection without the need for
specialized equipment [89].
A LAMP assay for species-speciﬁc rapid diagnosis of Plas-
modium species has been developed [90]. LAMP assays areand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 640–648
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positive and negative controls with results in <60 min. Samples
with 102 copies of P. knowlesi target sequence per LAMP re-
action were detected [90,91]. LAMP for rapid, affordable and
speciﬁc diagnosis of malaria, including P. knowlesi malaria, would
solve the current uncertainty and unreliability of microscopy
and aRDTs for malarial diagnosis. LAMP technology is suitable
for most areas where malaria is a problem, where malaria
elimination is a goal and where changes in the epidemiology of
P. knowlesi malaria would signal unusual outbreaks and hot spots
of transmission.SummaryPlasmodium knowlesi is the most common type of locally acquired
malaria in Malaysia. Transmission is normally in the jungle setting,
where the natural macaque hosts and Anopheline vectors of
P. knowlesi exist. People who spend time in the jungles of South-
East Asia are at risk. Parasitaemia is associated with disease
severity in P. knowlesi malaria and infections can be severe and
fatal. Rapid diagnosis is important because of the 24-h life cycle of
P. knowlesi and treatment with intravenous artesunate is rec-
ommended. The study of P. knowlesi pathophysiology is in its
infancy but there is evidence to suggest that some parasite
variants are more virulent than others. Currently there is no
speciﬁc diagnostic test for P. knowlesi although LAMP technology
for malaria detection, to include speciﬁc reagents for P. knowlesi,
shows most promise. The multiple ongoing entries of P. knowlesi
into the human population in South-East Asia suggest that
monitoring to detect changes in transmission and prevalence of
this important zoonosis would be prudent.Transparency declarationThe authors declare that they have no conﬂicts of interest.AcknowledgementsS.M. is supported by a University of St Andrews PhD
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